2566 Stock Chart & Stats
HK$9.31
HK$0.01(0.17%)
At close: 4:00 PM EST
HK$9.31
HK$0.01(0.17%)
Day’s Range― - ―
52-Week RangeHK$4.60 - HK$12.71
Previous CloseN/A
Volume181.60K
Average Volume (3M)35.61K
Market Cap
HK$1.38B
Enterprise ValueHK$883.32
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)8.8
Beta1.08
Next Earnings
Mar 31, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.15%
Share Statistics
EPS (TTM)0.43
Shares Outstanding245,398,800
10 Day Avg. Volume57,700
30 Day Avg. Volume35,613
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Hangzhou Jiuyuan Gene Engineering Co Ltd Class H News
2566 FAQ
What was Hangzhou Jiuyuan Gene Engineering Co Ltd Class H’s price range in the past 12 months?
Hangzhou Jiuyuan Gene Engineering Co Ltd Class H lowest stock price was HK$4.60 and its highest was HK$12.71 in the past 12 months.
What is Hangzhou Jiuyuan Gene Engineering Co Ltd Class H’s market cap?
Hangzhou Jiuyuan Gene Engineering Co Ltd Class H’s market cap is HK$1.38B.
When is Hangzhou Jiuyuan Gene Engineering Co Ltd Class H’s upcoming earnings report date?
Hangzhou Jiuyuan Gene Engineering Co Ltd Class H’s upcoming earnings report date is Mar 31, 2027 which is in 186 days.
How were Hangzhou Jiuyuan Gene Engineering Co Ltd Class H’s earnings last quarter?
Hangzhou Jiuyuan Gene Engineering Co Ltd Class H released its earnings results on Aug 19, 2026. The company reported HK$0.43 earnings per share for the quarter.
Is Hangzhou Jiuyuan Gene Engineering Co Ltd Class H overvalued?
According to Wall Street analysts Hangzhou Jiuyuan Gene Engineering Co Ltd Class H’s price is currently Overvalued.
Does Hangzhou Jiuyuan Gene Engineering Co Ltd Class H pay dividends?
Hangzhou Jiuyuan Gene Engineering Co Ltd Class H pays a Annually dividend of HK$0.066 which represents an annual dividend yield of 1.15%. See more information on Hangzhou Jiuyuan Gene Engineering Co Ltd Class H dividends here
What is Hangzhou Jiuyuan Gene Engineering Co Ltd Class H’s EPS estimate?
Hangzhou Jiuyuan Gene Engineering Co Ltd Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hangzhou Jiuyuan Gene Engineering Co Ltd Class H have?
Hangzhou Jiuyuan Gene Engineering Co Ltd Class H has 245,398,800 shares outstanding.
What happened to Hangzhou Jiuyuan Gene Engineering Co Ltd Class H’s price movement after its last earnings report?
Hangzhou Jiuyuan Gene Engineering Co Ltd Class H reported an EPS of HK$0.43 in its last earnings report. Following the earnings report the stock price went down -2.064%.
Which hedge fund is a major shareholder of Hangzhou Jiuyuan Gene Engineering Co Ltd Class H?
Currently, no hedge funds are holding shares in HK:2566
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Hangzhou Jiuyuan Gene Engineering Co Ltd Class H Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-48.25%
12-Months-Change
Fundamentals
Return on Equity
1.15%
Trailing 12-Months
Asset Growth
11.39%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Hangzhou Jiuyuan Gene Engineering Co Ltd Class H
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, manufacturing, and commercialization of biopharmaceutical products and medical devices in Mainland China and internationally. The company offers Guyoudao, a bone repair material; Jilifen, a human granulocyte colony stimulating factor injection; Jijufen, a human interleukin-11 injection; Jiouting, a palonosetron hydrochloride injection; Jifuwei, a fulvestrant injection; Jitansu, a fosaprepitant dimeglumine injection; and Jixinfen, PEG-GCSF injection. It also provides Jilixin avatrombopag maleate tablets; Jipailin, a low molecular weight heparin sodium injection; and Yinuojia, an enoxaparin sodium injection. The company was formerly known as Hangzhou Jiuyuan Gene Engineering Co., Ltd. and changed its name to Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. in April 2025. Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. was incorporated in 1993 and is headquartered in Hangzhou, China.
Hangzhou Jiuyuan Gene Engineering Co Ltd Class H (2566) Earnings & Revenues
Technical Analysis
Genscript Biotech
―
Wuxi Biologics (Cayman)
―
Pharmaron Beijing Co., Ltd. Class H
―
Frontage Holdings Corp.
―
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
―